Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX)
Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks with high potential. In a report released on October 3, Jason Gerberry from Bank of America Securities maintained a Buy rating on Vaxcyte, Inc. (NASDAQ:PCVX) and set a price target of $134.00. Is Chevron Corporation (CVX) the Low Volatility Stock to Buy According to Billionaire Ken Fisher? In other news, Vaxcyte, Inc. (NASDAQ:PCVX) reported on September 30 that it entered into a new agreement with Thermo Fisher Scientific Inc. to “bring additi ...